NetworkNewsBreaks - Foresight Autonomous Holdings
Post# of 218
Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision, today announced that it will begin a pilot project for its prototype COVID-19 symptom detection mass screening solution. According to the update, Meuhedet, one of Israel’s largest health maintenance organizations (“HMOs”), will evaluate the technology for several months. “As the COVID-19 virus continues to spread, it is of great concern to find a solution that will help to detect early symptoms of the coronavirus and offer a solution aimed at preventing another pandemic outbreak,” Haim Siboni, CEO of Foresight, said in the news release. “This first pilot project with a leading Israeli HMO validates the need for Foresight’s new screening solution in high-traffic areas such as health clinics. Based on the large number of Mehuedet clinics throughout Israel, a successful pilot project may lead to further evaluation and future commercial orders.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer